---
title: "Top Urologist Endorses ProstatID for Prostate Health"
url: https://burnaze.com/article/bf5b03b8-bf7e-4b24-9aa2-01edb0cdd8b6
source: "Franchise Magazine USA"
original_url: https://franchisemagazineusa.com/top-urologist-endorses-prostatid-for-prostate-health/
category: "Health"
industry: "Health"
topics: ["Technology"]
published: 2024-02-14T15:59:24.000Z
modified: 2026-11-01T01:04:31.737Z
image: https://images.unsplash.com/photo-1581090464777-f3220bbe1b8b?w=1600&q=80&auto=format&fit=crop
---

# Top Urologist Endorses ProstatID for Prostate Health

**TL;DR:** Dr. D. Russell Locke, a top urologist from Vantage Urologic Institute, endorses ProstatID for its efficiency and precision in radiology reporting for prostate health. ProstatID has significantly facilitated his practice by providing quick results and enhancing communication with patients.

*originally published in Franchise Magazine USA on 2024-02-14. [Read the original](https://franchisemagazineusa.com/top-urologist-endorses-prostatid-for-prostate-health/).*

## Story

Dr. D. Russell Locke M.D., from Vantage Urologic Institute, shares his experience with the revolutionary ProstatID from Bot Image Inc.

I am frankly astounded by the capabilities of ProstatID. As a urologist, I have found it to be remarkably efficient in providing quick results which has significantly facilitated my practice. ProstatID goes beyond typical radiology reporting by offering a visual understanding of prostate conditions, enhancing communication with patients, and guiding diagnostic and treatment decisions with exceptional precision.

In my experience, ProstatID has consistently demonstrated its profound impact. On numerous occasions, I have encountered significant disparities between ProstatID’s findings and conventional radiological assessments. In many cases where patients had multiple negative MRIs but persistent clinical symptoms indicative of underlying cancer, ProstatID revealed previously undetected cancerous lesions. This discovery has been pivotal in guiding targeted biopsies and therapeutic interventions, ultimately leading to more accurate diagnoses and improved patient outcomes.

Additionally, through retrospective analysis, ProstatID has revealed a concerning trend in the progression of lesions from minor suspicion to significant pathology over time. This invaluable insight has informed proactive management strategies, allowing for early interventions and disease progression prevention.

From a practical standpoint, I have seamlessly integrated ProstatID’s 3D outputs into cognitive biopsies, surpassing the limitations of traditional fusion systems. The precision and clarity provided by ProstatID’s axial and coronal views have significantly enhanced biopsy procedures, ensuring precise alignment and optimal treatment guidance.

Without a doubt, every urologist dealing with prostate conditions should incorporate ProstatID into their practice. Its indispensable role in improving diagnostic accuracy and guiding therapeutic interventions makes it an indispensable tool in the realm of urology. To forego the utilization of ProstatID would be a disservice to both patients and practitioners alike.

## Entities

- Franchise Magazine USA (publication)
- Health (sector)
- endorsement (topic)
- prostate health (topic)
- radiology reporting (topic)
- medical technology (topic)

---
Originally reported by Franchise Magazine USA (https://franchisemagazineusa.com/top-urologist-endorses-prostatid-for-prostate-health/). Summarized by Burnaze (https://burnaze.com/article/bf5b03b8-bf7e-4b24-9aa2-01edb0cdd8b6).